NASDAQ:ALDX

Aldeyra Therapeutics Stock Insider Trading

etoro logo Buy ALDX
*Your capital is at risk
$2.05
+0.0900 (+4.59%)
At Close: Jun 22, 2026

Aldeyra Therapeutics Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -29.07. In total, the insiders bought 5.15M and sold 6.9M ALDX shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
-29.07
Buy 5.15M shares
Sell 6.9M shares
92% Buy Activity
Negligible or No Correlation
Buy Signal Low Confidence
Jun 03, 2026

Analysis Breakdown:

  • Signal is highly questionable due to a strongly contradictory negative Insider Power Score of -29.07.
  • Confidence increased due to high data reliability score of 100.
  • Supported by overwhelming buy-side pressure (92% buys).

Historical Insider Trades

Date Type Person Role Amount
Jun 10, 2025
Buy
Stock Option (Right to Buy)
A-Award
Joyce Martin Joseph
Director
Director 62 728
Value: $168.4K
Jun 10, 2025
Buy
Stock Option (Right to Buy)
A-Award
Bronstein Ben
Director
Director 3 619
Value: $10K
Jun 10, 2025
Buy
Stock Option (Right to Buy)
A-Award
Bronstein Ben
Director
Director 62 728
Value: $168.4K
Jun 10, 2025
Buy
Stock Option (Right to Buy)
A-Award
Miller-rich Nancy
Director
Director 2 413
Value: $6K
Jun 10, 2025
Buy
Stock Option (Right to Buy)
A-Award
Miller-rich Nancy
Director
Director 62 728
Value: $168.4K
Jun 10, 2025
Buy
Stock Option (Right to Buy)
A-Award
Walker Neal
Director
Director 2 413
Value: $6K
Jun 10, 2025
Buy
Stock Option (Right to Buy)
A-Award
Walker Neal
Director
Director 62 728
Value: $168.4K
Apr 17, 2025
Buy
Stock Option (Right to Buy)
A-Award
Clark William D
Director
Director 76 760
Value: $168.1K
Apr 17, 2025
Buy
Common Stock
J-Other
Clark William D
Insider
Other 0
Value: $0
Apr 17, 2025
Buy
Common Stock
J-Other
Clark William D
Insider
Other 0
Value: $0
Apr 17, 2025
Buy
Stock Option (Right to Buy)
A-Award
Clark William D
Director
Director 76 760
Value: $168.1K
Apr 03, 2025
Sell
Common Stock
S-Sale
Perceptive Advisors Llc
10 Percent Owner
10% Owner 3 400 000
Value: $4.83M
Apr 03, 2025
Sell
Common Stock
S-Sale
Perceptive Advisors Llc
10 Percent Owner
10% Owner 3 400 000
Value: $4.83M
Mar 04, 2025
Buy
Stock Option (right to buy)
A-Award
Machatha Stephen
Chief Development Officer
Officer 202 427
Value: $1.25M
Mar 04, 2025
Buy
Stock Option (right to buy)
A-Award
Machatha Stephen
Chief Development Officer
Officer 202 427
Value: $1.25M
Aug 31, 2024
Buy
Common Stock
J-Other
Alfieri Michael
Insider
Other 0
Value: $0
Aug 31, 2024
Buy
Common Stock
J-Other
Alfieri Michael
Insider
Other 0
Value: $0
Aug 12, 2024
Sell
Common Stock
S-Sale
Machatha Stephen
Chief Development Officer
Officer 16 041
Value: $76.0K
Aug 12, 2024
Sell
Common Stock
S-Sale
Greenberg Bruce
See Remarks
Officer 10 834
Value: $51.3K
Aug 12, 2024
Sell
Common Stock
S-Sale
Greenberg Bruce
See Remarks
Officer 10 834
Value: $51.3K
Aug 12, 2024
Sell
Common Stock
S-Sale
Machatha Stephen
Chief Development Officer
Officer 16 041
Value: $76.0K
Jun 10, 2024
Buy
Stock Option (Right to Buy)
A-Award
Bronstein Ben
Director
Director 3 860
Value: $10.4K
Jun 10, 2024
Buy
Stock Option (Right to Buy)
A-Award
Bronstein Ben
Director
Director 3 860
Value: $10.4K
Jun 04, 2024
Buy
Stock Option (Right to Buy)
A-Award
Douglas Richard
Director
Director 40 282
Value: $164.8K
Jun 04, 2024
Buy
Stock Option (Right to Buy)
A-Award
Douglas Richard
Director
Director 10 418
Value: $42.6K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT ALDEYRA THERAPEUTICS
Aldeyra Therapeutics
Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It also develops ADX-629, a first-in-class orally administered RASP modulator that is Phase II clinical tria...
GOLDEN STAR
Ticker Change Signal Date
IDYA
$28.98
18.12% Jun 12
DHI
$146.71
6.29% Jun 10
PHM
$118.49
6.02% Jun 10
EAT
$140.46
17.09% Jun 05
E
ETD
$20.67
3.19% Jun 05

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE